EOLS — EVOLUS INC

Ownership history in Frazier Life Sciences Management, L.P.  ·  3 quarters on record

This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in EVOLUS INC (EOLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.9% (2025 Q2)
Avg. % of fund
0.62%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 2,630,665 — 0% 0.47% $17.5M $6.65
2025 Q3 ADDED 2,630,665 +195,115 +8.0% 0.48% $16.2M $6.14
2025 Q2 INITIATED 2,435,550 — — 0.90% $22.4M $9.21
% of Fund (quarterly)    EOLS price (monthly, adj. close)

Other funds also holding EOLS

As of 2025 Q4 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 7.92% AWH Capital, L.P. 3Y 7Y 3.83% Buckley Capital Advisors, LLC 3.48% Soviero Asset Management, LP 3Y 2.09% CM Management, LLC 3Y 1.4% Nantahala Capital Management, LLC 3Y 7Y 1.28% BRAIDWELL LP 3Y 0.66% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.42% Seven Fleet Capital Management LP 0.41% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.41%
← Back to Frazier Life Sciences Management, L.P. Holdings